An experimental mouse model of musk antibody positive myasthenia gravis

An experimental mouse model of musk antibody positive myasthenia gravis

Détails bibliographiques
Auteurs principaux:	Viegas, S, Waters, P, Jacobsen, L, Vincent, A
Format:	Journal article
Publié:	2008

Documents similaires

PATHOGENIC MECHANISMS UNDERLYING MYASTHENIA GRAVIS ASSOCIATED WITH MUSK ANTIBODIES
par: Viegas, S, et autres
Publié: (2009)

Myasthenia gravis with MuSK antibodies
par: Farrugia, M, et autres
Publié: (2005)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
par: Vincent, A, et autres
Publié: (2006)

Facial muscle atrophy in musk antibody positive myasthenia gravis
par: Farrugia, M, et autres
Publié: (2006)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
par: Lee, J, et autres
Publié: (2006)

Clinical and immunological correlates in myasthenia gravis associated with musk antibodies
par: Viegas, S, et autres
Publié: (2008)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
par: Nilesh Wagh, et autres
Publié: (2024-09-01)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
par: McConville, J, et autres
Publié: (2002)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
par: Chang, T, et autres
Publié: (2009)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
par: Diana Epure, et autres
Publié: (2016-06-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
par: Yung-Chuan Huang, et autres
Publié: (2008-07-01)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
par: McConville, J, et autres
Publié: (2004)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
par: J Gordon Millichap
Publié: (2006-08-01)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
par: Shiraishi, H, et autres
Publié: (2005)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
par: Amber Eker, et autres
Publié: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
par: Zunwei Zhang, et autres
Publié: (2020-10-01)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
par: Newsom-Davis, J, et autres
Publié: (2001)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
par: Bennett, D, et autres
Publié: (2006)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
par: Christiane Schneider-Gold, et autres
Publié: (2017-10-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
par: Farrugia, M, et autres
Publié: (2007)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
par: Ting LI, et autres
Publié: (2020-01-01)

Potential mechanisms in MuSK-myasthenia gravis
par: Koneczny, I
Publié: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
par: Shalini Bhaskar, et autres
Publié: (2022-01-01)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
par: Niks, E, et autres
Publié: (2006)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
par: Yeh, J, et autres
Publié: (2004)

Anti-musk positive myasthenia gravis and three semiological cardinal signs
par: André P.C. Matta, et autres
Publié: (2017-01-01)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
par: Koneczny, I, et autres
Publié: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
par: Koneczny, I, et autres
Publié: (2014)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
par: Aigli G. Vakrakou, et autres
Publié: (2023-07-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
par: Shan CAO, et autres
Publié: (2019-02-01)

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
par: Dipesh Chhetri, et autres
Publié: (2025-02-01)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
par: Cao, M
Publié: (2021)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
par: Lee, J, et autres
Publié: (2016)

MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
par: Benveniste, O, et autres
Publié: (2005)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
par: Phillips, W, et autres
Publié: (2015)

Clinical and functional characteristics of seronegative and musk myasthenia gravis
par: Huda, S
Publié: (2017)

Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
par: S. Lanfranconi, et autres
Publié: (2011-01-01)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
par: Fangyi Shi, et autres
Publié: (2024-11-01)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
par: Farrugia, M, et autres
Publié: (2006)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
par: Hoch, W, et autres
Publié: (2001)